Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Martin A. Lehr | Co-Founder, President, CEO & Director | 674.08k | -- | 1984 |
| Ms. Jennifer Minai-Azary | CFO & Treasurer | 504.14k | -- | 1978 |
| Mr. Alex C. Levit Esq. | Chief Legal Officer & Corporate Secretary | 483.83k | -- | 1979 |
| Mr. Christopher Beck M.B.A. | Senior Vice President of Operations | -- | -- | -- |
| Dr. Claudio Dansky Ullmann M.D. | Chief Medical Officer | -- | -- | -- |
Context Therapeutics Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 5
Description
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
November 12, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission